NNC0363-1063

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 1

Phase 1

A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes

CompletedNCT06685185

Novo Nordisk A/SDiabetes Mellitus, Type 1

Start: 2024-11-12End: 2026-03-18Updated: 2026-04-09

A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes

CompletedNCT07305805

Novo Nordisk A/SDiabetes Mellitus, Type 1

Start: 2025-12-16End: 2026-05-08Updated: 2026-06-05